These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21187924)

  • 21. Glioblastoma cells negative for the anti-CD133 antibody AC133 express a truncated variant of the CD133 protein.
    Osmond TL; Broadley KW; McConnell MJ
    Int J Mol Med; 2010 Jun; 25(6):883-8. PubMed ID: 20428792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
    J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.
    Tirino V; Camerlingo R; Franco R; Malanga D; La Rocca A; Viglietto G; Rocco G; Pirozzi G
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):446-53. PubMed ID: 19464919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of CD133 promotes drug resistance in C6 glioma cells.
    Angelastro JM; Lamé MW
    Mol Cancer Res; 2010 Aug; 8(8):1105-15. PubMed ID: 20663862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57.
    Zhu X; Prasad S; Gaedicke S; Hettich M; Firat E; Niedermann G
    Oncotarget; 2015 Jan; 6(1):171-84. PubMed ID: 25426558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines.
    Zito G; Richiusa P; Bommarito A; Carissimi E; Russo L; Coppola A; Zerilli M; Rodolico V; Criscimanna A; Amato M; Pizzolanti G; Galluzzo A; Giordano C
    PLoS One; 2008; 3(10):e3544. PubMed ID: 18958156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SPECT imaging of colorectal cancer by targeting CD 133 receptor with 99mTc-labeled monoclonal antibody.
    Liu Y; Jin X; Lan X; Lang J; Wen Q; An R
    Q J Nucl Med Mol Imaging; 2019 Jun; 63(2):216-224. PubMed ID: 27387378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ultrastructural difference between CD133-positive U251 glioma stem cells and normal U251 glioma cells.
    Yang B; Wang Y; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
    Ultrastruct Pathol; 2012 Dec; 36(6):404-8. PubMed ID: 23216238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.
    Wei XD; Zhou L; Cheng L; Tian J; Jiang JJ; Maccallum J
    Head Neck; 2009 Jan; 31(1):94-101. PubMed ID: 18853445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
    Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of the stem cell marker prominin-1/CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cells.
    Bourseau-Guilmain E; Griveau A; Benoit JP; Garcion E
    PLoS One; 2011; 6(9):e25515. PubMed ID: 21966538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced invasion in vitro and the distribution patterns in vivo of CD133+ glioma stem cells.
    Yu SP; Yang XJ; Zhang B; Ming HL; Chen C; Ren BC; Liu ZF; Liu B
    Chin Med J (Engl); 2011 Sep; 124(17):2599-604. PubMed ID: 22040410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological and genetic characteristics of tumor-initiating cells in colon cancer.
    Ieta K; Tanaka F; Haraguchi N; Kita Y; Sakashita H; Mimori K; Matsumoto T; Inoue H; Kuwano H; Mori M
    Ann Surg Oncol; 2008 Feb; 15(2):638-48. PubMed ID: 17932721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospectively isolated cancer-associated CD10(+) fibroblasts have stronger interactions with CD133(+) colon cancer cells than with CD133(-) cancer cells.
    Cui L; Ohuchida K; Mizumoto K; Moriyama T; Onimaru M; Nakata K; Nabae T; Ueki T; Sato N; Tominaga Y; Tanaka M
    PLoS One; 2010 Aug; 5(8):e12121. PubMed ID: 20711432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus.
    Bach P; Abel T; Hoffmann C; Gal Z; Braun G; Voelker I; Ball CR; Johnston IC; Lauer UM; Herold-Mende C; Mühlebach MD; Glimm H; Buchholz CJ
    Cancer Res; 2013 Jan; 73(2):865-74. PubMed ID: 23293278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting CD133high Colorectal Cancer Cells In Vitro and In Vivo With an Asymmetric Bispecific Antibody.
    Zhao L; Yang Y; Zhou P; Ma H; Zhao X; He X; Wang T; Zhang J; Liu Y; Zhang T
    J Immunother; 2015; 38(6):217-28. PubMed ID: 26049545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics.
    Liu A; Feng B; Gu W; Cheng X; Tong T; Zhang H; Hu Y
    Int J Oncol; 2013 Apr; 42(4):1399-407. PubMed ID: 23416969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.
    Shmelkov SV; Butler JM; Hooper AT; Hormigo A; Kushner J; Milde T; St Clair R; Baljevic M; White I; Jin DK; Chadburn A; Murphy AJ; Valenzuela DM; Gale NW; Thurston G; Yancopoulos GD; D'Angelica M; Kemeny N; Lyden D; Rafii S
    J Clin Invest; 2008 Jun; 118(6):2111-20. PubMed ID: 18497886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel mouse CD133 binding-peptide screened by phage display inhibits cancer cell motility in vitro.
    Sun J; Zhang C; Liu G; Liu H; Zhou C; Lu Y; Zhou C; Yuan L; Li X
    Clin Exp Metastasis; 2012 Mar; 29(3):185-96. PubMed ID: 22228571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.